StockData
IRadimed Corp logo

IRadimed Corp (IRMD) stock

IRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3057% above fair value
$83.45−1.39 (-1.64%)

Close on Nov 17, 2026Market cap $1.07BP/E 44.6Yield –

IRadimed price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

IRadimed's price to sales ratio was 12.8× on Nov 11, 2026, against 14.7× a year earlier. Over the last 5 years it ranged from 7.1× to 15.8×, with a median of 9.8×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202612.8×−2.5
2025Dec 31, 202515.4×+5.6
2024Dec 31, 20249.8×+0.3
2023Dec 29, 20239.5×+2.4
2022Dec 30, 20227.1×−7.8
2021Dec 31, 202114.8×+6.6
2020Dec 31, 20208.2×+0.8
2019Dec 31, 20197.4×−1.9
2018Dec 31, 20189.3×+2.1
2017Dec 29, 20177.1×+3.8
2016Dec 30, 20163.4×−8.4
2015Dec 31, 201511.8×+2.9
2014Dec 31, 20148.9×–

More IRadimed figures

See a number that looks wrong?